Medeon Biodesign, Inc.
Research Medeon Biodesign, Inc. (6499.TWO) on Bullrun: market cap TWD 8.09B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker6499.TWO
- ExchangeTWO
- CountryTaiwan
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyTWD
- Market capTWD 8.09B
- Financial periodQ2 2026
- RevenueTWD 106.61M
- Net income-TWD 124.77M
- Free cash flow-TWD 93.41M
- Gross margin11.1%
Valuation Snapshot
latest market cap is TWD 8.09B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 8.09B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 TWD.
About Medeon Biodesign, Inc.
Medeon Biodesign, Inc. engages in the research and development, manufacturing, and sale of medical devices in the United States. The company focuses on developing devices for minimally invasive surgeries, such as Cross-Seal, a large bore vascular closure system; Urocross, an expander system for treating lower urinary tract symptoms associated with benign prostatic hyperplasia; Duett, a vascular graft system; PUMA, solution to treat orthopedic extremity injuries;
ETFs that hold Medeon Biodesign, Inc.
US-listed ETFs
Medeon Biodesign, Inc. is held by one US-listed ETF, going by the latest portfolio it filed with the SEC:
| ETF | Weight | Fee |
|---|---|---|
| State Street SPDR S&P Emerging Markets Small Cap ETF (EWX) | 0.01% | 0.65% |
Portfolios as filed with the SEC on Form N-PORT, dated June 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Medeon Biodesign, Inc.'s market cap?
Medeon Biodesign, Inc.'s market capitalization is TWD 8.09B.
What does Medeon Biodesign, Inc. do?
Medeon Biodesign, Inc. engages in the research and development, manufacturing, and sale of medical devices in the United States.